ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT
Report
- Report Number
- 3005094123-2025-00071
- Event Type
- Malfunction
- Date Received
- February 12, 2025
- Date of Event
- January 24, 2025
- Report Date
- February 12, 2025
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- MMI
- UDI-DI
- 00380740160630
- PMA / PMN Number
- N/A
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 8P13 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 4Z21, WITH 510K/PMA/BLA NUMBER K042924. THE COMPLAINT INVESTIGATION FOR FALSELY ELEVATED ALINITY I STAT HIGH SENSITIVITY TROPONIN-I RESULTS INCLUDED A REVIEW OF DATA AND INFORMATION PROVIDED BY THE CUSTOMER, SEARCH FOR SIMILAR COMPLAINTS, TICKET TRENDING REVIEW, LABELING REVIEW, DEVICE HISTORY RECORD REVIEW, AND FIELD DATA REVIEW. RETURN TESTING WAS NOT COMPLETED AS RETURNS WERE NOT AVAILABLE. DATA AND INFORMATION PROVIDED BY THE CUSTOMER WERE REVIEWED AND SUPPORT THE COMPLAINT ISSUE WITHOUT INDICATION FOR ANY ADDITIONAL ISSUE. REVIEW OF TRACKING AND TRENDING FOR THE ALINITY I STAT HIGH SENSITIVITY TROPONIN-I ASSAY DID NOT IDENTIFY AN INCREASE IN COMPLAINT ACTIVITY RELATED TO THE COMPLAINT ISSUE. ADDITIONALLY, AN INCREASE IN COMPLAINT ACTIVITY WAS NOT IDENTIFIED FOR REAGENT LOT 65189UD00. DEVICE HISTORY RECORD REVIEW FOR LOT 65189UD00 DID NOT IDENTIFY ANY NON-CONFORMANCES, POTENTIAL NONCONFORMANCES, OR DEVIATIONS WITH THE COMPLAINT LOT. THE OVERALL PERFORMANCE WAS REVIEWED USING DATA GATHERED FROM CUSTOMERS WORLDWIDE. THE MEDIAN POPULATION RESULT FOR THE LOT IS WITHIN ESTABLISHED LIMITS, INDICATING THAT THE LOT IS PERFORMING ACCEPTABLY IN THE FIELD. LABELING WAS REVIEWED AND SUFFICIENTLY ADDRESSES THE CUSTOMER'S ISSUE. BASED ON THE INVESTIGATION, NO SYSTEMIC ISSUE OR DEFICIENCY WITH THE ALINITY I STAT HIGH SENSITIVITY TROPONIN-I ASSAY FOR LOT 65189UD00 WAS IDENTIFIED. ALL AVAILABLE PATIENT INFORMATION WAS INCLUDED. ADDITIONAL PATIENT DETAILS ARE NOT AVAILABLE.
THE CUSTOMER OBSERVED FALSELY ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN-I RESULTS FOR ONE PATIENT SAMPLE. THE FOLLOWING RESULTS WERE PROVIDED: (CUSTOMER PROVIDED REFERENCE RANGE < 26.2 PG/ML) INITIAL RESULT = 3000-4000 PG/ML, SO THE PATIENT WAS REFERRED TO ANOTHER HOSPITAL. BLOOD WAS TAKEN AGAIN AT THE OTHER HOSPITAL TEST ON UNKNOWN METHOD = 0.92NG/ML, RETEST RESULT = 0.6 NG/ML (EQUIVALENT VALUE 920 PG/ML, 600 PG/ML). THE CUSTOMER REPORTED OTHER TESTS WERE PERFORMED, POSSIBLY EKG OR ECHOCARDIOGRAM, SHOWING NO EVIDENCE OF CARDIAC ABNORMALITIES. NO FURTHER IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1042061 | ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT | IMMUNOASSAY METHOD, TROPONIN SUBUNIT | MMI | ABBOTT IRELAND DIAGNOSTICS DIVISION | 65189UD00 | 00380740160630 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | ALNTY I PROCESSING MODU, 03R65-01, (B)(6). |